Day: May 7, 2024

Company to host conference call to discuss financial results and provide a corporate update on May 13, 2024 at 4:30 p.m. ET SCOTTSDALE, Ariz., May 07, 2024 (GLOBE NEWSWIRE) — Journey Medical Corporation (“Journey Medical” or the “Company”) (Nasdaq: DERM), a commercial-stage pharmaceutical company that focuses on the selling and marketing of FDA-approved prescription pharmaceutical products for the treatment of dermatological conditions, today announced the Company will release its first quarter 2024 financial results after the U.S. financial markets close on Monday, May 13, 2024. Journey Medical management will conduct a conference call and audio webcast on Monday, May 13, 2024 at 4:30 p.m. ET. To listen to the conference call, interested parties within the U.S. should dial 1-866-777-2509 (domestic) or 1-412-317-5413 (international)....

WOBURN, Mass., May 07, 2024 (GLOBE NEWSWIRE) — Bridgeline Digital, Inc. (NASDAQ: BLIN), a global leader in AI-powered marketing technology, announces its strategic partnership with Be A Part Of, an award-winning ecommerce agency. This collaboration between Bridgeline’s site search product, HawkSearch, and Be a Part Of signals a significant advancement in revolutionizing ecommerce search experiences for brands worldwide. Be A Part Of leverages HawkSearch’s state-of-the-art capabilities in ecommerce search, product discovery, and recommendations to enhance online shopping journeys for its client roster of global brands, wholesalers, and retailers. By integrating HawkSearch’s technology, Be A Part Of aims to empower brands to elevate engagement, drive conversions, and maximize revenue across their digital platforms. Ari...

Earnings Webinar Scheduled For 1:00 p.m. ET, May 9, 2024 CALGARY, Alberta, May 07, 2024 (GLOBE NEWSWIRE) — CEMATRIX Corporation (TSXV: CVX) (OTCQB: CTXXF) (“CEMATRIX” or the “Company“), a North American leading manufacturer and supplier of technologically advanced cellular concrete products, today announced that it will release its consolidated financial results for the first quarter ending March 31, 2024, after the market closes on May 8, 2024. Management will host a webinar at 1:00 p.m. ET on Thursday, May 9, 2024, to discuss CEMATRIX’s first quarter financial results, provide a corporate update and conclude with a question-and-answer session from online participants. To participate, please use the following information: You are invited to a Zoom webinar.When: May 9, 2024 11:00 AM Mountain Time (US and...

SEATTLE, May 07, 2024 (GLOBE NEWSWIRE) — Atossa Therapeutics, Inc. (Nasdaq: ATOS) (“Atossa” or the “Company”) today announced its support of new guidelines released by the U.S. Preventive Services Task Force (USPSTF) recommending that women begin breast cancer screening starting at age 40. Atossa is a clinical stage biopharmaceutical company developing innovative medicines in areas of significant unmet medical need in oncology with a focus on breast cancer. The updated guidelines recommend women undergo biennial mammography screening beginning at the age of 40 until the age of 74. The change to the recommended age comes in response to rising breast cancer rates among younger women and racial disparities in breast cancer diagnosis and mortality. The announced changes from USPSTF also come in advance of a September 2024 deadline...

Barfresh Secures 443 New School Customer Locations Across Multiple States, Serving Barfresh Products to Over 360,000 Students Customer Growth Acceleration Fuels Company’s Projected Record Fiscal Year 2024 Revenue and Year Over Year Margin Expansion LOS ANGELES, May 07, 2024 (GLOBE NEWSWIRE) — Barfresh Food Group Inc. (the “Company” or “Barfresh”) (Nasdaq: BRFH), a provider of frozen, ready-to-blend and ready-to-drink beverages, reinforced its education channel sales momentum today by announcing new multi-state customer wins, broadening its reach in this key market. The Company recently secured 443 new school locations, representing a collective population of over 360,000 students. These new school locations plan to introduce a varied selection of the Company’s products, including its Twist & Go carton and bottled smoothie...

SAN DIEGO, May 07, 2024 (GLOBE NEWSWIRE) — KULR Technology Group, Inc. (NYSE American: KULR) (the “Company” or “KULR”), “), a global leader in safe and high-performance energy storage solutions, today announced the Company has successfully completed large format fractional thermal runaway calorimeter (“L-FTRC”) tests for 200 Amp-hour (Ah) high energy Nickel Manganese Cobalt (NMC) prismatic format lithium-ion cells for its global automotive OEM customer. As the exclusive licensee of the L-FTRC technology from NASA, KULR is uniquely positioned to service customers in electric vehicles, grid energy storage and industrial applications with L-FTRC testing of their batteries in the global cell testing market estimated to reach USD $7 billion by 2030. Just last year, a leading global automaker selected KULR...

Biopharma industry veteran joins Scorpius’ leadership team DURHAM, N.C., May 07, 2024 (GLOBE NEWSWIRE) — Scorpius Holdings, Inc. (NYSE American: SCPX) (“Scorpius” or the “Company”), an integrated contract development and manufacturing organization (CDMO), today announced the appointment of Shari Udoff-McDonald as VP of Business Development. She brings more than 25 years of experience in biopharma business development and management. Prior to joining Scorpius, Ms. Udoff-McDonald spent 17 years at BioReliance Corporation, part of MilliporeSigma. She was most recently Head of Commercial, North America, East with interim oversight of half of the European market. Her role included commercial oversight of biologics, vaccines, cell and gene therapies, ADCs, and mRNA GMP testing services for sponsors and CDMOs. Joe Payne, Scorpius’ President...

Generous Government Tax Incentives Spur Renewed Interest in Grom’s Manila-based Studio from International Programming Suppliers BOCA RATON, Fla., May 07, 2024 (GLOBE NEWSWIRE) — Grom Social Enterprises Inc. (NASDAQ: GROM) (“Grom” or the “Company”), a media, technology and entertainment company dedicated to family-friendly programming, web filtering technology, and safe social media for kids, today announced that its subsidiary, Top Draw Animation (“TDA”), a leading source of premium animation production services for programming shown throughout the world, will lend its animation expertise to over $2.9MM in new assignments, one of which represents the largest single order in Top Draw’s 25-year history. The new production work – unnamed for competitive reasons – was announced today by Grom CEO, Darren Marks. “The global animation...

The company’s revolutionary, patent-protected bipolar electrode-to-pack technology dramatically reduces battery weight, volume, and cost DAYTON, Ohio, May 07, 2024 (GLOBE NEWSWIRE) — Solidion Technology, Inc. (Nasdaq: STI), an advanced battery technology solutions provider, today unveiled their patent-protected bipolar electrode-to-pack (BEEP) technology. Rather than creating individual cells and modules, Solidion’s BEEP technology produces a high-voltage, high-capacity battery pack by stacking and connecting bipolar electrodes and solid electrolyte layers in series and in parallel. Solid-state batteries are expected to revolutionize the electric vehicle industry with their inherent safety, fast charging, and an achievable range of over 900 miles on a single charge. However, two major issues have prevented the wide-spread commercialization...

Real Brands Inc.Dr. Richard J. Goldberg has joined Real Brands Inc.’s Board of Directors and will consult for them on research and development of psychedelic drug therapies.North Providence, RI, May 07, 2024 (GLOBE NEWSWIRE) — Real Brands Inc. (OTCPK: RLBD) announced today that it has added Richard J. Goldberg, MD, MS, to its Board of Directors, and The Company has entered into a consulting agreement with Dr. Goldberg for guidance and expertise in Real Brand’s new Psychedelics research division that was launched in 2023.Dr. Richard J. Goldberg has joined Real Brands Inc.’s Board of Directors and will consult for them on research and development of psychedelic drug therapies. “Dr. Goldberg is a renowned, award-winning medical expert in Psychiatry who we are engaging to play a key role in developing strategy...